Moderna expects R&D costs to drop by $1.1B by 2027



Moderna Inc. published a report on Thursday sharing the company’s progress updates and research and development (R&D) strategy.”Moderna now has five respiratory vaccines with positive Phase 3 resu…
About the author:

Get involved!

Fai trading in gruppo!
L'unica Academy di trading completamente gratuita per gli utenti FpMarkets

Comments

Ancora nessun commento